Around noon on Thursday, short-seller Citron Research offered some free advice to President-Elect Donald Trump: If Trump is serious about cutting prescription drug costs, go after Express Scripts.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include IBM, Qualcomm, Valeant, Yum China, CSX and DeVry.
November 8, 2016: Here are four stocks trading with relatively heavy volume among 128 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by nearly 3 to…
Over the past month, Valeant Pharmaceuticals sank to just above its 52-week low, but it appears that it has now been pushed over the edge with this most recent earnings report.
Chris Lange Halfway through the third quarter, it looked like Joe Papa had really turned this company around, as Valeant Pharmaceuticals shares were up nearly double from their lows, but it has been a…
Chris Lange 24/7 Wall St. has put together a preview of Disney, Petrobras and some of the other major companies reporting their quarterly results this week.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include American Electric Power, Broadcom, Ford, General Motors, JD.com, Sarepta Therapeutics and Valeant Pharmaceuticals.
Shares of Valeant Pharmaceuticals saw a handy gain in Monday’s session after the company announced that it has appointed a new chief financial officer.
Chris Lange Although some analysts have become less negative and upgraded to a more neutral view on Valeant Pharmaceuticals, Morgan Stanley's is a true call to buy the stock.
Chris Lange The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Cisco, Cree, Exxon Mobil, Hewlett Packard Enterprise, Urban Outfitters, Valeant Pharmaceuticals, Western Digital.
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.
Valeant Pharmaceuticals International appears to have a turnaround underway, after the company reported its second-quarter financial results before the markets opened on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of Valeant Pharmaceuticals, Alibaba and some of the other major companies reporting their quarterly results this coming week
Shares of Progenics Pharmaceuticals and Valeant Pharmaceuticals made handy gains in the market on Wednesday following a key FDA approval that could be a real turning point for the companies.
Chris Lange There is no indication that Fiat Chrysler has done anything wrong, but it has other problems that could compound its current hardships with regulators and drive its stock price down even further.
